1. Home
  2. PKOH vs CSTL Comparison

PKOH vs CSTL Comparison

Compare PKOH & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

N/A

Current Price

$46.31

Market Cap

686.7M

Sector

Industrials

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$35.31

Market Cap

722.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PKOH
CSTL
Founded
1907
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
686.7M
722.8M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
PKOH
CSTL
Price
$46.31
$35.31
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $45.11
AVG Volume (30 Days)
48.1K
★ 254.6K
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 1.08%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.43
N/A
Revenue
★ $1,599,100,000.00
$344,229,000.00
Revenue This Year
$7.26
$8.41
Revenue Next Year
$3.99
$10.30
P/E Ratio
$32.98
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$18.43
$17.72
52 Week High
$53.30
$44.28

Technical Indicators

Market Signals
Indicator
PKOH
CSTL
Relative Strength Index (RSI) 46.88 63.06
Support Level $44.01 $33.90
Resistance Level $47.51 $36.85
Average True Range (ATR) 1.31 1.46
MACD -0.14 -0.07
Stochastic Oscillator 30.61 86.78

Price Performance

Historical Comparison
PKOH
CSTL

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: